A small private university in Japan is focused on creating seamless connections to cultivate new drugs from basic research, and having a measurable impact on the world stage. 02 October 2024 ...
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 18 scientific posters, ...
In this free webinar, see how AI can deliver practical value across the CNS trial journey today in eCOA, imaging and rater training. Attendees will gain insight into the role for AI-supported vocal ...
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...
A new compound, called VU319, has delivered promising results in a Phase 1 trial for treating Alzheimer’s disease and other neudegenerative conditions. The corresponding study was published in ACS ...
AbbVie has a blockbuster mental health medication in Vraylar, but the psychiatric drug pipeline behind it is thin. The pharmaceutical giant is bolstering its drug prospects through a new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results